Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: Summary of an ecological study

Influenza and other Respiratory Viruses

Volumn 7, Issue SUPPL.2, 2013, Pages 82-86

  Miller, Paula E ^a   Rambachan, Aksharananda ^a   Hubbard, Roderick J ^a   Li, Jiabai ^a   Meyer, Alison E ^a   Stephens, Peter ^b   Mounts, Anthony W ^c   Rolfes, Melissa A ^d   Penn, Charles R ^c  

^a ST OLAF COLLEGE   (United States)

^b IQVIA   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antivirals; Epidemiology; Global health; Influenza

Indexed keywords

OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

CLINICAL INDICATOR; DRUG USE; ECOLOGY; HEALTH CARE DELIVERY; HUMAN; INFLUENZA A (H1N1); MORBIDITY; MORTALITY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SOCIOECONOMICS; WORLD HEALTH ORGANIZATION;

ANTIVIRALS; EPIDEMIOLOGY; GLOBAL HEALTH; INFLUENZA;

ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRAL PROTEINS; ZANAMIVIR;

EID: 84883164665     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12092     Document Type: Review

References (22)

1. Makela MJ, Pauksens K, Rostila T et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 2000; 40:42-48.
2. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003; 326:1235.
3. Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011; 53:277-279.
4. Treanor JJ, Hayden FG, Vrooman PS et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016-1024.
5. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006; 442:448-452.
6. Germann TC, Kadau K, Longini IM, Makcen CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci USA 2006; 103:5935-5940.
7. Inglesby TV, Nuzzo JB, O'Toole T, Henderson DA. Disease mitigation measures in the control of pandemic influenza. Biosecur Bioterror 2006; 4:366-375.
8. Hsu J, Santesso N, Mustafa R et al. Antivirals for treatment of influenza: evidence from observational studies. Ann Intern Med 2012; 156:512-524.
9. Nguyen-Van-Tam JS, Openshaw PJM, Hashim A et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010; 65:645-651.
10. Lee EH, Wu C, Lee EU et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50:1498-1504.
11. Xi X, Xu Y, Jiang L, Li A, Duan J, Du B. Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infect Dis 2010; 10:256.
12. Maliszewski PJ, Wei R. Ecological factors associated with pandemic influenza A (H1N1) hospitalization rates in California (USA): a geospatial analysis. Geospat Health 2011; 6:95-105.
13. Nikolopoulos G, Bagos P, Lytras T, Bonovas S. An ecological study of the determinants of differences in 2009 pandemic influenza mortality rates between countries in Europe. PLoS ONE 2011; 6:e19432.
14. Higuera Iglesias AL, Kudo K, Manabe T et al. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico. PLoS ONE 2011; 6:e21838.
15. United Nations, United Nations Children's Fund: ChildInfo. Available at http://www.unicef.org/statistics/index_24296.html (Accessed 12 January 2011).
16. UNAIDS/WHO. UNAIDS report on the global AIDS epidemic (Accessed 15 January 2011).
17. United Nations, United Nations Statistics Division: Statistical Databases. Available at http://unstats.un.org/unsd/databases.htm (Accessed 15 January 2011).
18. United Nations, United Nations Population Division World Population Prospects: the 2008 Revision Population Database. Available at http://esa.un.org/unpp/ (Accessed 15 January 2011).
19. International Obesity Task Force. Obesity prevalence worldwide. Available at http://www.iaso.org/iotf/obesity/ (Accessed 15 January 2011).
20. World Health Organization. World Health Organization Statistical Information System (WHOSIS). Available at http://www.who.int/whosis/en/ (Accessed 15 January 2011).
21. World Health Organization. Global health observatory. Available at http://www.who.int/gho/database/en/ (Accessed 15 January 2011).
22. The Fund for Peace. Failed states index 2010. Available at http://www.fundforpeace.org/web/index.php?option=com_content&task=view&id=452&Itemid=900 (Accessed 15 January 2011).